Raysearch Laboratories AB (publ) Interim report January 1 – June 30, 2016
“Revenues from RayStation® rose 100 percent to SEK 107.8 M (53.9) and prospects are favorable for the rest of the year.The development of RayCare® is progressing as planned and we will demonstrate the system at the 2016 ASTRO radiation therapy conference in Boston at the end of September,” says Johan Löf, President and CEO of RaySearch. SECOND QUARTER (APRIL - JUNE 2016) · Net sales SEK 119.0 M (77.3), of which RayStation SEK 107.8 M (53.9) · Profit after tax SEK 28.8 M (loss: 2.6) and earnings per share were SEK 0.84 (loss: 0.08) · Operating profit SEK 37.5 M (loss: 2.1)